title: Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
abstract: We recently showed that the administration of the antidiuretic V2 specific agonist, 1-desamino[8-D-arginine]vasopressin (dDAVP), to seven male patients with congenital nephrogenic diabetes insipidus (CNDI) did not cause a decrease in blood pressure nor an increase in plasma renin activity or factor VIIIc or von Willebrand factor release. In normal subjects, plasma renin activity, coagulation factors and plasma cyclic AMP are stimulated not only by dDAVP but also by the administration of epinephrine. In the present study, we measured tissue plasminogen activator (activity and antigenicity), von Willebrand factor multimers, plasma and urinary cyclic AMP concentrations following dDAVP or epinephrine administration. We infused epinephrine into three male patients with CNDI. Factor VIIIc and tissue plasminogen activator augmented by 75 to 100% and von Willebrand Factor multimers were increased; plasma renin activity and plasma cyclic AMP concentration increased by 200%. None of these values changed when the same subjects as well as eleven other male patients with CNDI received dDAVP. Furthermore, dDAVP administration increased plasma cyclic AMP concentrations in normal subjects, but not in 14 male patients with CNDI. These results demonstrate the specificity of the extrarenal V2 receptor defect expressed in our patients. The lack of a plasma cyclic AMP response to the administration of dDAVP would suggest an altered pre-cyclic AMP stimulation mechanism.
authors.affiliation: Service de néphrologie, Hôpital du Sacré-Coeur de Montréal Canada.
authors.forename: D G
authors.initials: DG
authors.lastname: Bichet
authors.forename: M
authors.initials: M
authors.lastname: Razi
authors.forename: M F
authors.initials: MF
authors.lastname: Arthus
authors.forename: M
authors.initials: M
authors.lastname: Lonergan
authors.forename: P
authors.initials: P
authors.lastname: Tittley
authors.forename: R K
authors.initials: RK
authors.lastname: Smiley
authors.forename: G
authors.initials: G
authors.lastname: Rock
authors.forename: D J
authors.initials: DJ
authors.lastname: Hirsch
mesh_terms: D000328:Adult; D001779:Blood Coagulation Factors / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D003894:Deamino Arginine Vasopressin; D003919:Diabetes Insipidus / Q000151:congenital / Q000378:metabolism*; D004837:Epinephrine; D006801:Humans; D008297:Male; D009399:Nephrons / Q000378:metabolism; D011945:Receptors, Angiotensin / Q000378:metabolism*; D017483:Receptors, Vasopressin
chemical_list: D001779:Blood Coagulation Factors; D011945:Receptors, Angiotensin; D017483:Receptors, Vasopressin; D000242:Cyclic AMP; D003894:Deamino Arginine Vasopressin; D004837:Epinephrine